- Home
- PROK vs EMX Comparison
PROK vs EMX Comparison
Compare PROK & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- EMX
- Stock Information
- Founded
- PROK 2015
- EMX N/A
- Country
- PROK United States
- EMX Canada
- Employees
- PROK N/A
- EMX N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- EMX
- Sector
- PROK Health Care
- EMX
- Exchange
- PROK Nasdaq
- EMX Nasdaq
- Market Cap
- PROK 206.0M
- EMX 202.9M
- IPO Year
- PROK N/A
- EMX N/A
- Fundamental
- Price
- PROK $1.50
- EMX $1.81
- Analyst Decision
- PROK Buy
- EMX Strong Buy
- Analyst Count
- PROK 5
- EMX 1
- Target Price
- PROK $4.50
- EMX $7.00
- AVG Volume (30 Days)
- PROK 344.0K
- EMX 323.6K
- Earning Date
- PROK 03-21-2025
- EMX 03-24-2025
- Dividend Yield
- PROK N/A
- EMX N/A
- EPS Growth
- PROK N/A
- EMX N/A
- EPS
- PROK N/A
- EMX N/A
- Revenue
- PROK N/A
- EMX $26,818,000.00
- Revenue This Year
- PROK N/A
- EMX N/A
- Revenue Next Year
- PROK N/A
- EMX $2.34
- P/E Ratio
- PROK N/A
- EMX N/A
- Revenue Growth
- PROK N/A
- EMX 25.53
- 52 Week Low
- PROK $1.34
- EMX $1.47
- 52 Week High
- PROK $4.44
- EMX $2.15
- Technical
- Relative Strength Index (RSI)
- PROK 41.47
- EMX 51.89
- Support Level
- PROK $1.50
- EMX $1.72
- Resistance Level
- PROK $1.67
- EMX $1.91
- Average True Range (ATR)
- PROK 0.10
- EMX 0.06
- MACD
- PROK -0.00
- EMX -0.00
- Stochastic Oscillator
- PROK 10.71
- EMX 47.37
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco, and Australia.